BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
-0.340 (-7.52%)
At close: Mar 20, 2026, 4:00 PM EDT
4.470
+0.290 (6.94%)
After-hours: Mar 20, 2026, 6:39 PM EDT

BriaCell Therapeutics Balance Sheet

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Cash & Equivalents
21.957.570.8621.2541.0457.27
Short-Term Investments
-5.32----
Cash & Short-Term Investments
21.9512.890.8621.2541.0457.27
Cash Growth
337.77%1395.51%-95.94%-48.22%-28.34%269412.38%
Accounts Receivable
1.671.492.795.70.020.01
Other Current Assets
----1.280.52
Total Current Assets
23.6214.383.6526.9542.3557.8
Net Property, Plant & Equipment
0.180.210.39---
Other Intangible Assets
0.130.130.2-0.230.25
Long-Term Investments
0.430.380.420.2200
Other Long-Term Assets
0.30.521.21---
Total Assets
24.6615.625.8727.1642.5858.04
Accounts Payable
1.382.377.171.120.460.21
Accrued Expenses
0.960.50.290.680.480.34
Total Current Liabilities
2.342.877.461.80.940.56
Other Long-Term Liabilities
0.140.241.129.1431.3129.82
Total Long-Term Liabilities
0.140.241.129.1431.3129.82
Total Liabilities
2.483.118.5630.9432.2530.37
Common Stock
85.9673.4272.1769.5965.5954.77
Additional Paid-in Capital
30.1820.2311.037.425.232.18
Accumulated Other Comprehensive Income
-0.1-0.1-0.14-0.14-0.14-0.14
Retained Earnings
-93.34-80.64-85.44-80.65-60.35-29.14
Total Common Shareholders' Equity
22.6912.9-2.38-3.7810.3327.67
Minority Interest
-0.52-0.39-0.3---
Shareholders' Equity
22.1812.51-2.68-3.7810.3327.67
Total Liabilities & Equity
24.6615.625.8727.1642.5858.04
Net Cash (Debt)
21.9512.890.8621.2541.0457.27
Net Cash Growth
70.24%1395.51%-95.94%-48.22%-28.34%-
Net Cash Per Share
14.7930.477.86204.08397.331900.69
Book Value
22.6912.9-2.38-3.7810.3327.67
Book Value Per Share
15.2930.50-21.72-36.27100.00918.39
Tangible Book Value
22.5612.77-2.58-3.7810.127.43
Tangible Book Value Per Share
15.2030.18-23.54-36.2797.77910.24
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q